US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 0.799
- +0.011+1.43%
Close Nov 21 16:00 ET
- 0.820
- +0.021+2.60%
Post 17:22 ET
3.44MMarket Cap-95P/E (TTM)
0.845High0.743Low46.83KVolume0.780Open0.788Pre Close37.05KTurnover1.20%Turnover RatioLossP/E (Static)4.31MShares12.36652wk High-4.84P/B3.13MFloat Cap0.61052wk Low--Dividend TTM3.92MShs Float23999.988Historical High--Div YieldTTM13.01%Amplitude0.610Historical Low0.791Avg Price1Lot Size
About Bio-Path Holdings Company
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Company Profile
SymbolBPTH
Company NameBio-Path Holdings
Listing DateMar 10, 2014
Issue Price0.50
Founded2007
CEOMr. Peter H. Nielsen
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address4710 Bellaire Boulevard,Suite 210
CityBellaire
ProvinceTexas
CountryUnited States of America
Zip Code77401
Phone1-832-742-1357
Company Executives
- Name
- Position
- Salary
- Peter H. Nielsen
- Chairman of the Board, Chief Executive Officer, President, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 827.12K
- Douglas P. Morris
- Director, Secretary and Director, Investor Relations
- 89.98K
- Aline B. Sherwood
- Independent Director
- 76.81K
- Heath W. Cleaver, C.P.A.
- Independent Director
- 85.31K
- Paul D. Aubert
- Independent Director
- 73.81K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data